therapy

Recently, TRIPP PsyAssist completed its Phase 1 Feasibility Study to demonstrate its use as a pretreatment tool for patients undergoing ketamine therapy. This VR solution is an example of emerging technologies that facilitate the development of more accessible and transformative mental health care solutions. Globally, more than 500 million people have anxiety and depression. That’s […]